0001610618-21-000071.txt : 20210827
0001610618-21-000071.hdr.sgml : 20210827
20210827184108
ACCESSION NUMBER: 0001610618-21-000071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210825
FILED AS OF DATE: 20210827
DATE AS OF CHANGE: 20210827
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ward Shane
CENTRAL INDEX KEY: 0001638380
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 211220457
MAIL ADDRESS:
STREET 1: C/O VERSARTIS, INC.
STREET 2: 4200 BOHANNON DR., SUITE 250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
4
1
wf-form4_163010405399223.xml
FORM 4
X0306
4
2021-08-25
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001638380
Ward Shane
6310 NANCY RIDGE DRIVE
SUITE 101
SAN DIEGO
CA
92121
0
1
0
0
CHIEF LEGAL OFFICER
Stock Option (right to buy)
2.16
2021-08-25
4
A
0
250000
0
A
2031-08-24
Common Stock
250000.0
250000
D
25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of August 25, 2021; 1/48th of the shares subject to the option shall vest monthly thereafter, such that all shares will be vested on August 25, 2025.
/s/ Shane Ward
2021-08-27